iShares Nasdaq Biotechnology ETF (IBB)

Add to Watchlists
Create an Alert
336.85 +0.47  +0.14% NASDAQ Oct 16, 16:59 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Key Stats

IBB Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 0.74% 0.70% 0.24% 32
3M 6.35% 6.35% 3.53% 19
6M 15.87% 15.74% 12.97% 25
1Y 24.36% 24.25% 20.53% 29
3Y 9.52% 9.53% 10.88% 63
5Y 19.05% 19.04% 16.88% 31
10Y 14.72% 14.68% 11.57% 15
As of Oct. 13, 2017. Returns for periods of 1 year and above are annualized.

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.05% 0.05% 0.01%
Stock 99.95% 99.95% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of Oct. 12, 2017

IBB Region Exposure

Americas 98.41%
North America 98.41%
Latin America 0.00
Greater Europe 1.26%
United Kingdom 0.52%
Europe Developed 0.67%
Europe Emerging 0.00
Africa/Middle East 0.07%
Greater Asia 0.33%
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.33%
Market Classification
% Developed Markets 99.67%
% Emerging Markets 0.33%
As of Oct. 12, 2017. Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 99.93%
Industrials 0.00
Real Estate 0.00
Technology 0.07%
Utilities 0.00
As of Oct. 12, 2017

IBB Stock Market Capitalization

Giant 24.10%
Large 32.40%
Medium 21.98%
Small 13.38%
Micro 8.13%
As of Oct. 12, 2017

IBB Stock Style Exposure

Large Cap Value 10.22%
Large Cap Blend 16.79%
Large Cap Growth 31.26%
Mid Cap Value 3.08%
Mid Cap Blend 1.54%
Mid Cap Growth 17.36%
Small Cap Value 1.10%
Small Cap Blend 3.80%
Small Cap Growth 14.86%
As of Oct. 12, 2017
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
BIIB Biogen Inc 8.42% 335.65 -0.59%
AMGN Amgen Inc 8.22% 181.91 -0.60%
CELG Celgene Corp 7.97% 136.72 +0.19%
GILD Gilead Sciences Inc 7.77% 79.92 -1.54%
REGN Regeneron Pharmaceuticals Inc 6.56% 444.60 +0.37%
ILMN Illumina Inc 4.07% 206.17 -0.36%
ALXN Alexion Pharmaceuticals Inc 3.97% 140.86 +0.18%
VRTX Vertex Pharmaceuticals Inc 3.84% 154.50 +1.04%
INCY Incyte Corp 3.28% 116.65 +2.05%
MYL Mylan NV 2.97% 38.18 +0.61%
As of Oct. 12, 2017
Advertisement

IBB One Page Reports

IBB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 1.46 yrs
Diane Hsiung 9.75 yrs
Greg Savage 9.75 yrs
Jennifer Hsui 5.17 yrs

IBB Net Fund Flows

1M 541.45M
3M 132.16M
6M 863.13M
YTD 799.57M
1Y 1.541B
3Y 3.546B
5Y 4.300B
10Y 4.723B
As of Sept. 30, 2017

IBB Risk Info

Beta (5Y) 1.365
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.7983
Historical Sortino (All) 0.5957
30-Day Rolling Volatility 8.98%
Daily Value at Risk (VaR) 1% (All) 4.85%
Monthly Value at Risk (VaR) 1% (All) 19.62%

IBB Fundamentals

Dividend Yield TTM (10-16-17) 0.20%
SEC Yield (12-31-15) 0.00%
Weighted Average PE Ratio 23.47
Weighted Average Price to Sales Ratio 6.330
Weighted Average Price to Book Ratio 5.306
Weighted Median ROE 8.33%
Weighted Median ROA -2.42%
Forecasted Dividend Yield 0.52%
Forecasted PE Ratio 21.30
Forecasted Price to Sales Ratio 5.116
Forecasted Price to Book Ratio 3.967
Number of Holdings 161
As of Oct. 12, 2017

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 9.41%
Forecasted Book Value Growth 16.21%
Forecasted Cash Flow Growth 16.40%
Forecasted Earnings Growth 12.51%
Forecasted Revenue Growth 14.97%
As of Oct. 12, 2017

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Last Annual Report Date 3/31/2017
Last Prospectus Date 8/1/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.